New combo treatment tested for tough breast cancers
Disease control
Not yet recruiting
This early study aims to check if it is safe and tolerable to give a targeted cancer drug (a CDK4/6 inhibitor) at the same time as standard radiation therapy after surgery. It will involve 30 women with a specific high-risk type of breast cancer (HR+/HER2-). Researchers will clos…
Phase: EARLY_PHASE1 • Sponsor: Guizhou Provincial People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC